Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Healthcare Today.
Press releases published on June 12, 2025
Teacher / Nurse Next Door Buyers Secure Seller Concessions at Twice the National Average
EIN Presswire
·
June 12, 2025
Aligned homebuying strategy reduces closing costs for educators and public servants nationwide TAMPA BAY, FL, UNITED STATES, June 12, 2025 /EINPresswire.com/ -- In an increasingly competitive housing market, the Teacher Next Door Program is delivering a …
Health 2.0 Conference’s Dubai 2025 Edition To Investigate Healthcare Fraud Schemes
EIN Presswire
·
June 12, 2025
This 2025 health conference will feature expert sessions on addressing healthcare fraud, boosting public trust, and enhancing patient safety. DUBAI, NV, UNITED ARAB EMIRATES, June 12, 2025 /EINPresswire.com/ -- The Health 2.0 Conference, set to be held …
Chemical Peel Market Is Booming Worldwide | Obagi, Murad, Glytone
EIN Presswire
·
June 12, 2025
The Global Chemical Peel Market is projected to grow from $2.1 Billion in 2025 to $3.4 Billion by 2034, at a CAGR of 5.4%. HYDERABAD, TELANGANA, INDIA, June 12, 2025 /EINPresswire.com/ -- USD Analytics just released the Global Chemical Peel Market Study …
Clamps Market Detailed in New Research Report, Expected to Cross USD 270.42 Million by 2032 | B. Braun Melsungen AG
EIN Presswire
·
June 12, 2025
Clamps Market Research Report Information By Product Type, By End User, And By Region FL, UNITED STATES, June 12, 2025 /EINPresswire.com/ -- Clamps Insights The Clamps Market is expected to expand its roots at a CAGR of 2.8% during 2022 to 2032. The …
Zopiclone Market Set to Witness Strong Growth, Reaching USD 2.5 Billion by 2033 | Sun Pharmaceutical Industries Ltd.
EIN Presswire
·
June 12, 2025
Zopiclone Market Research Report Information By Medicine Type, By Distribution Channel, And By Region CA, UNITED STATES, June 12, 2025 /EINPresswire.com/ -- Zopiclone Insights The Zopiclone Market was worth USD 1.5 billion in 2024 and is projected to …
ePharmacy Market Will Hit Big Revenue In Future | BestKenko, Healthkart, PharmEasy
EIN Presswire
·
June 12, 2025
The Global ePharmacy Market is projected to grow from $98.5 Billion in 2025 to $460.8 Billion by 2034, at a CAGR of 18.7%. HYDERABAD, TELANGANA, INDIA, June 12, 2025 /EINPresswire.com/ -- USD Analytics just released the Global ePharmacy Market Study, a …
Blue Sky Scrubs Honors World Blood Donor Day With a Call to Action: Promoting Health, Hope, and Humanity
EIN Presswire
·
June 12, 2025
Blue Sky Scrubs Honors World Blood Donor Day With a Call to Action: Promoting Health, Hope, and Humanity …
ProHance Releases Global Benchmarking Report 2023–Q1 2025, Reveals Productivity Trends Across Hybrid Workforces
EIN Presswire
·
June 12, 2025
Analysis of workforce data reveals key productivity benchmarks, performance trends, and hybrid model impacts across industries and geographies. BENGALURU, INDIA, June 12, 2025 /EINPresswire.com/ -- ProHance, a new-age workplace analytics and operations …
Daré Bioscience Announces Adjournment of Annual Meeting of Stockholders
GlobeNewswire
·
June 12, 2025
SAN DIEGO, June 12, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company driven by a mission to challenge the status quo, making women's health a priority, today announced that the company’s 2025 annual meeting of …
Hapbee Is Upgrading U.S. Listing to OTCID to Expand Investor Access and Increase Market Visibility
GlobeNewswire
·
June 12, 2025
VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies Inc. (TSXV: HAPB | OTC: HAPBF) (“Hapbee” or the “Company”), a leading wearable wellness technology company, is pleased to announce that its U.S. listing has been upgraded …
Bipolar Disorder Therapeutics Market to Reach USD 10,970M by 2035 | Fact.MR Report
EIN Presswire
·
June 12, 2025
Analysis of Bipolar Disorder Therapeutics Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries ROCKVILLE, MD, UNITED STATES, June 12, 2025 /EINPresswire.com/ -- In 2025, the Bipolar Disorder …
Banner Health’s clinical leader driving care innovation
GlobeNewswire
·
June 12, 2025
PHOENIX, June 12, 2025 (GLOBE NEWSWIRE) -- Marjorie Bessel, MD, chief clinical officer at Banner Health, has been recognized as one of Modern Healthcare’s 50 Most Influential Clinical Executives for 2025. It is the third time in five years she has won this …
DraftKings to Introduce Transaction Fee in Illinois
GlobeNewswire
·
June 12, 2025
BOSTON, June 12, 2025 (GLOBE NEWSWIRE) -- In response to the recent and prior sports wagering tax increases passed by the Illinois state legislature on all mobile and online sports wagers placed with licensed operators, DraftKings Inc. (Nasdaq: DKNG) today …
Agoraphobia Market Epidemiology Report 2025-2035: Drug Pipeline, Treatment, Trends, Rising Incidence & prevalence
EIN Presswire
·
June 12, 2025
The report provides a detailed analysis of the current agoraphobia marketed drugs and late-stage pipeline drugs, advancements in treatment, …
DBV Technologies participera au prochain congrès EAACI 2025
GlobeNewswire
·
June 12, 2025
Châtillon, France, le 12 juin (22:30 CEST) 2025 DBV Technologies participera au prochain congrès EAACI 2025 DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market: DBVT ; CUSIP : 23306J309), une société biopharmaceutique en phase …
DBV Technologies to Participate in Upcoming EAACI Congress 2025
GlobeNewswire
·
June 12, 2025
Châtillon, France, June 12, 2025 DBV Technologies to Participate in Upcoming EAACI Congress 2025 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, today …
FibroGen Announces 1-for-25 Reverse Stock Split
GlobeNewswire
·
June 12, 2025
SAN FRANCISCO, June 12, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that it will implement a 1-for-25 reverse stock split of its issued and outstanding common stock ("Reverse Stock Split"), effective at 5:00 p.m. Eastern Time on …
Galapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025, Highlighting Low Toxicity and Rapid, Decentralized Delivery of Fresh, Early-Memory-Enriched GLPG5101 in R/R NHL
GlobeNewswire
·
June 12, 2025
Data reported from the ongoing ATALANTA-1 Phase 1/2 study in a heavily pretreated relapsed refractory non-Hodgkin’s Lymphoma (R/R NHL) patient population demonstrate low rates of high-grade toxicities Of the 64 patients enrolled, 61 received treatment, …
Galapagos zal nieuwe ATALANTA-1 CAR-T data presenteren op EHA 2025, met lage toxiciteit en snelle, gedecentraliseerde toediening van vers, early-memory-verrijkt GLPG5101 bij R/R NHL
GlobeNewswire
·
June 12, 2025
Gegevens uit de lopende ATALANTA-1 fase 1/2-studie bij een zwaar voorbehandelde patiëntengroep met recidief/refractair non-Hodgkinlymfoom (R/R NHL) tonen lage percentages van hooggradige toxiciteiten aan Van de 64 ingeschreven patiënten werden er 61 …
Starton Therapeutics Announces Phase 2a Clinical Trial for Continuous Low-Dose Lenalidomide (STAR-LLD) in Multiple Myeloma Open for Enrollment
GlobeNewswire
·
June 12, 2025
Gabrail Cancer …